Number of participants sustaining recurrent patellar dislocation · people with lateral patellar dislocation
It is very uncertain whether surgical changes number of participants sustaining recurrent patellar dislocationa compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Kujala patellofemoral disorders score Scale from: 0 to 100 (higher scores = better function) · people with lateral patellar dislocation
It is very uncertain whether surgical changes knee and physical functiona Measured using the Kujala patellofemoral… compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Adverse effects of treatment Overall incidence of complications · people with lateral patellar dislocation
It is very uncertain whether surgical changes adverse effects of treatment Overall incidence of complications compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Patient satisfactiona Reported as 'good' or 'excellent'. · people with lateral patellar dislocation
It is very uncertain whether surgical changes patient satisfactiona Reported as 'good' or 'excellent'. compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Patient‐reported knee instabilitya Incidence of patellar subluxation · people with lateral patellar dislocation
It is very uncertain whether surgical changes patient‐reported knee instabilitya Incidence of patellar subluxation compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Proportion of children who received DTP3 or Penta 3 by 1 year of age · children under 5 years of age
Health education may leads to higher proportion of children who received DTP3/Penta 3 by 1 year of age compared with routine care (low certainty).
1 finding from 1 review
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study (measles) · children under 5 years of age
Engagement of community leaders probably leads to higher proportion of children who received the vaccine under study (measles) compared with routine care (moderate certainty).
1 finding from 1 review
Proportion of children under 5 years of age fully immunised with all scheduled vaccines · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received DTP3 or Penta 3 by 1 year of age · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received all recommended vaccines by 2 years of age · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study (BCG) · children under 5 years of age
It is very uncertain whether monetary incentives changes proportion of children who received the vaccine under study (BCG) compared with routine care (very low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (measles/MMR) ‐ household monetary incentivef · children under 5 years of age
It is very uncertain whether monetary incentives changes proportion of children who received the vaccine under study… compared with routine care (very low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (MMR) ‐ service‐level monetary incentiveg · children under 5 years of age
It is very uncertain whether monetary incentives changes proportion of children who received the vaccine under study (MMR) ‐… compared with routine care (very low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (MMR) ‐ household + service‐level monetary incentive · children under 5 years of age
It is very uncertain whether monetary incentives changes proportion of children who received the vaccine under study (MMR) ‐… compared with routine care (very low certainty).
1 finding from 1 review